>> "A Nordic study involving Finland, Sweden, Norway and Denmark found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk tha

>> "A Nordic study involving Finland, Sweden, Norway and Denmark found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk than others of developing myocarditis," he said. > I find it frustrating that we’re still not putting numbers on statements like this in news articles. This article on the same general topic has numbers: https://www.nytimes.com/2021/10/06/health/covid-vaccine-children-dose.html https://www.nytimes.com/2021/10/06/health/covid-vaccine-chil... > A New Vaccine Strategy for Children: Just One Dose, for Now > Myocarditis, a rare side effect, occurs mostly after the second dose. So in some countries, officials are trying out single doses for children.... > Officials in Hong Kong as well as in Britain, Norway and other countries have recommended a single dose of the Pfizer-BioNTech vaccine for children ages 12 and older — providing partial protection from the virus, but without the potential harms occasionally observed after two doses.... > Advisers to the Centers for Disease Control and Prevention reviewed data on myocarditis in June, and unanimously voted to recommend the vaccine for children ages 12 and older, saying the benefits far outweighed the risk. > Agency research has estimated that for every million vaccinated boys ages 12 to 17 in the United States, the shots might cause a maximum of 70 myocarditis cases, but they would prevent 5,700 infections, 215 hospitalizations and two deaths. Studies have also shown that the risk of heart problems after Covid-19 is much higher than after vaccination.... > The latest analysis, which was published on Wednesday in The New England Journal of Medicine, found that the incidence of myocarditis after vaccination in Israel was highest among males aged 16 to 29. About 11 of every 100,000 males in that age group developed the condition a few days after being vaccinated, a rate higher than most earlier estimates. (The risk was negligible in females of any age.) That article also had some interesting discussion about reducing vaccination for young people because of myocarditis. Whether that's a wise decision or not really depends on how well the country in question has contained COVID.